These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35572921)

  • 1. Cerebellar and/or Brainstem Lesions Indicate Poor Prognosis in Multiple Sclerosis: A Systematic Review.
    Yang Y; Wang M; Xu L; Zhong M; Wang Y; Luan M; Li X; Zheng X
    Front Neurol; 2022; 13():874388. PubMed ID: 35572921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis.
    Le M; Malpas C; Sharmin S; Horáková D; Havrdova E; Trojano M; Izquierdo G; Eichau S; Ozakbas S; Lugaresi A; Prat A; Girard M; Duquette P; Larochelle C; Alroughani R; Bergamaschi R; Sola P; Ferraro D; Grammond P; Grand' Maison F; Terzi M; Boz C; Hupperts R; Butzkueven H; Pucci E; Granella F; Van Pesch V; Soysal A; Yamout BI; Lechner-Scott J; Spitaleri D; Ampapa R; Turkoglu R; Iuliano G; Ramo-Tello C; Sanchez-Menoyo JL; Sidhom Y; Gouider R; Shaygannejad V; Prevost J; Altintas A; Fragoso YD; McCombe PA; Petersen T; Slee M; Barnett MH; Vucic S; Van Der Walt A; Kalincik T
    Mult Scler; 2021 Apr; 27(5):755-766. PubMed ID: 32538713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining high, medium and low impact prognostic factors for developing multiple sclerosis.
    Tintore M; Rovira À; Río J; Otero-Romero S; Arrambide G; Tur C; Comabella M; Nos C; Arévalo MJ; Negrotto L; Galán I; Vidal-Jordana A; Castilló J; Palavra F; Simon E; Mitjana R; Auger C; Sastre-Garriga J; Montalban X
    Brain; 2015 Jul; 138(Pt 7):1863-74. PubMed ID: 25902415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study.
    Ormerod IE; Miller DH; McDonald WI; du Boulay EP; Rudge P; Kendall BE; Moseley IF; Johnson G; Tofts PS; Halliday AM
    Brain; 1987 Dec; 110 ( Pt 6)():1579-616. PubMed ID: 3427402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and demographic predictors of long-term disability in patients with relapsing-remitting multiple sclerosis: a systematic review.
    Langer-Gould A; Popat RA; Huang SM; Cobb K; Fontoura P; Gould MK; Nelson LM
    Arch Neurol; 2006 Dec; 63(12):1686-91. PubMed ID: 17172607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teriflunomide for multiple sclerosis.
    He D; Zhang C; Zhao X; Zhang Y; Dai Q; Li Y; Chu L
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD009882. PubMed ID: 27003123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between damage to the cerebellar peduncles and clinical disability in multiple sclerosis.
    Preziosa P; Rocca MA; Mesaros S; Pagani E; Drulovic J; Stosic-Opincal T; Dackovic J; Copetti M; Caputo D; Filippi M
    Radiology; 2014 Jun; 271(3):822-30. PubMed ID: 24555637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features of CIS of the brainstem/cerebellum of the kind seen in MS.
    Sastre-Garriga J; Tintoré M; Nos C; Tur C; Río J; Téllez N; Castilló J; Horga A; Perkal H; Comabella M; Rovira A; Montalban X
    J Neurol; 2010 May; 257(5):742-6. PubMed ID: 19946780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon beta-1a for early multiple sclerosis: CHAMPS trial subgroup analyses.
    Beck RW; Chandler DL; Cole SR; Simon JH; Jacobs LD; Kinkel RP; Selhorst JB; Rose JW; Cooper JA; Rice G; Murray TJ; Sandrock AW
    Ann Neurol; 2002 Apr; 51(4):481-90. PubMed ID: 11921054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations between clinical and MRI involvement in multiple sclerosis: assessment using T(1), T(2) and MT histograms.
    Iannucci G; Minicucci L; Rodegher M; Sormani MP; Comi G; Filippi M
    J Neurol Sci; 1999 Dec; 171(2):121-9. PubMed ID: 10581378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis.
    Fisniku LK; Brex PA; Altmann DR; Miszkiel KA; Benton CE; Lanyon R; Thompson AJ; Miller DH
    Brain; 2008 Mar; 131(Pt 3):808-17. PubMed ID: 18234696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Predictors of 9-Year Disability in Pediatric Multiple Sclerosis.
    De Meo E; Bonacchi R; Moiola L; Colombo B; Sangalli F; Zanetta C; Amato MP; Martinelli V; Rocca MA; Filippi M
    Ann Neurol; 2021 May; 89(5):1011-1022. PubMed ID: 33598931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of exercise training in adults with multiple sclerosis with severe mobility disability: A systematic review and future research directions.
    Edwards T; Pilutti LA
    Mult Scler Relat Disord; 2017 Aug; 16():31-39. PubMed ID: 28755682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of gait analysis for measuring disease severity using inertial sensors in patients with multiple sclerosis: protocol for a systematic review and meta-analysis.
    Vienne-Jumeau A; Quijoux F; Vidal PP; Ricard D
    Syst Rev; 2019 Jan; 8(1):15. PubMed ID: 30621765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes.
    Cantó E; Tintoré M; Villar LM; Costa C; Nurtdinov R; Álvarez-Cermeño JC; Arrambide G; Reverter F; Deisenhammer F; Hegen H; Khademi M; Olsson T; Tumani H; Rodríguez-Martín E; Piehl F; Bartos A; Zimova D; Kotoucova J; Kuhle J; Kappos L; García-Merino JA; Sánchez AJ; Saiz A; Blanco Y; Hintzen R; Jafari N; Brassat D; Lauda F; Roesler R; Rejdak K; Papuc E; de Andrés C; Rauch S; Khalil M; Enzinger C; Galimberti D; Scarpini E; Teunissen C; Sánchez A; Rovira A; Montalban X; Comabella M
    Brain; 2015 Apr; 138(Pt 4):918-31. PubMed ID: 25688078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy for diffuse brainstem glioma in children and young adults.
    Hu X; Fang Y; Hui X; Jv Y; You C
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD010439. PubMed ID: 27378212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and diagnostic features of patients with familial multiple sclerosis.
    Andrijauskis D; Balnyte R; Keturkaite I; Vaitkus A
    Med Hypotheses; 2019 Oct; 131():109310. PubMed ID: 31443766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis.
    Brownlee WJ; Altmann DR; Prados F; Miszkiel KA; Eshaghi A; Gandini Wheeler-Kingshott CAM; Barkhof F; Ciccarelli O
    Brain; 2019 Aug; 142(8):2276-2287. PubMed ID: 31342055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical impact of cerebellar grey matter pathology in multiple sclerosis.
    Damasceno A; Damasceno BP; Cendes F
    PLoS One; 2014; 9(5):e96193. PubMed ID: 24789257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eye problems in children with multiple sclerosis.
    Steinlin MI; Blaser SI; MacGregor DL; Buncic JR
    Pediatr Neurol; 1995 Apr; 12(3):207-12. PubMed ID: 7619186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.